Topline Results Disappoint for Biotin in Progressive MS Topline Results Disappoint for Biotin in Progressive MS

A pharmaceutical-grade biotin product (MD1003) tested for progressive MS did not meet primary or secondary endpoints in a phase 3 study designed to confirm positive results of an earlier trial.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news